Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies02:49

Cancer Therapies

9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Any impact of pre-operative radiotherapy on renal function in retroperitoneal soft tissue sarcomas? A secondary ancillary analysis of the EORTC 62092 STRASS 1 trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Redefining radiotherapy: the gut as an active target in Immuno-Oncology.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Safety and efficacy of concurrent radiation therapy with amivantamab in patients with advanced EGFR- or MET-altered non-small cell lung cancer.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Clinical trial endpoints for metastases-directed therapy in oligometastatic cancer: a review and Delphi consensus on behalf of the EORTC-ESTRO OligoCare consortium.

The Lancet. Oncology·2026
Same author

Unusual Case of Neuromeningeal Late Relapse of POLE Mutated Endometrioid Carcinoma: A Case Report and Systematic Review.

Current oncology (Toronto, Ont.)·2026
Same author

Practice-changing clinical trials in radiation oncology: A 2024-2025 literature synthesis.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026

Related Experiment Video

Updated: Jan 10, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.1K

Radiotherapy for primary lung cancer: 2025 update.

Jonathan Khalifa1, Yasmine El Houat2, Sébastien Thureau3

  • 1Department of Radiation Oncology, Oncopole Claudius-Regaud, Toulouse, France; Inserm, U1037, Centre de recherches en cancérologie de Toulouse, Toulouse, France.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|November 28, 2025
PubMed
Summary
This summary is machine-generated.

The French Society for Radiation Oncology updated its lung cancer radiotherapy guidelines, detailing target volume and organ delineation methods. These recommendations aim to standardize and improve radiation oncology practices for lung cancer patients.

Keywords:
Asservissement respiratoireCancer du poumonChemoradiotherapyChimioradiothérapieGuidelinesImmunotherapyImmunothérapieLung cancerRadiotherapyRadiothérapieRadiothérapie stéréotaxiqueRecommandationsRespiratory gatingSFROSociété française de radiothérapie oncologiqueStereotactic radiotherapy

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.9K

Related Experiment Videos

Last Updated: Jan 10, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.1K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.9K

Area of Science:

  • Radiation Oncology
  • Medical Imaging

Background:

  • Lung cancer requires precise radiotherapy planning.
  • Standardized guidelines are crucial for effective treatment.
  • Previous recommendations needed updating to reflect current practices.

Purpose of the Study:

  • To provide updated recommendations for lung cancer radiotherapy.
  • To detail the delineation of target volumes and organs at risk.
  • To guide radiation oncologists in treatment planning.

Main Methods:

  • Review and update of existing French Society for Radiation Oncology guidelines.
  • Expert consensus on target volume delineation for lung cancer.
  • Detailed methodology for identifying organs at risk in radiotherapy planning.

Main Results:

  • Comprehensive updated recommendations for lung cancer radiotherapy indications.
  • Specific guidance on delineating planning target volumes (PTVs).
  • Precise instructions for contouring organs at risk (OARs) to minimize toxicity.

Conclusions:

  • The updated guidelines offer a standardized approach to lung cancer radiotherapy.
  • Accurate delineation of PTVs and OARs is essential for optimal treatment outcomes.
  • These recommendations will enhance the quality and consistency of lung cancer radiation therapy.